| Added by | lklinares |
|---|---|
| Group name | EquipeLL |
| Item Type | Journal Article |
| Title | GCN2 inhibition sensitizes arginine-deprived hepatocellular carcinoma cells to senolytic treatment |
| Creator | Missiaen et al. |
| Author | Rindert Missiaen |
| Author | Nicole M. Anderson |
| Author | Laura C. Kim |
| Author | Bailey Nance |
| Author | Michelle Burrows |
| Author | Nicolas Skuli |
| Author | Madeleine Carens |
| Author | Romain Riscal |
| Author | An Steensels |
| Author | Fuming Li |
| Author | M. Celeste Simon |
| Abstract | Hepatocellular carcinoma (HCC) is a typically fatal malignancy exhibiting genetic heterogeneity and limited therapy responses. We demonstrate here that HCCs consistently repress urea cycle gene expression and thereby become auxotrophic for exogenous arginine. Surprisingly, arginine import is uniquely dependent on the cationic amino acid transporter SLC7A1, whose inhibition slows HCC cell growth in vitro and in vivo. Moreover, arginine deprivation engages an integrated stress response that promotes HCC cell-cycle arrest and quiescence, dependent on the general control nonderepressible 2 (GCN2) kinase. Inhibiting GCN2 in arginine-deprived HCC cells promotes a senescent phenotype instead, rendering these cells vulnerable to senolytic compounds. Preclinical models confirm that combined dietary arginine deprivation, GCN2 inhibition, and senotherapy promote HCC cell apoptosis and tumor regression. These data suggest novel strategies to treat human liver cancers through targeting SLC7A1 and/or a combination of arginine restriction, inhibition of GCN2, and senolytic agents. |
| Publication | Cell Metabolism |
| Volume | 34 |
| Issue | 8 |
| Pages | 1151-1167.e7 |
| Date | 2022-08-02 |
| Journal Abbr | Cell Metab |
| Language | eng |
| DOI | 10.1016/j.cmet.2022.06.010 |
| ISSN | 1932-7420 |
| Library Catalog | PubMed |
| Extra | PMID: 35839757 PMCID: PMC9357184 |
| Tags | Arginine, Carcinoma, Hepatocellular, GCN2, hepatocellular carcinoma, Humans, Liver Neoplasms, original, Protein Serine-Threonine Kinases, senescence, Senotherapeutics, urea cycle |
| Date Added | 2024/12/03 - 09:12:56 |
| Date Modified | 2024/12/03 - 09:12:56 |
| Notes and Attachments | PubMed entry (Attachment) |
Institut de Recherche en Cancérologie de
